site stats

Geron financials

WebWuchan Zhongda Geron Co.,Ltd. announced on 12 April 2024 the final profit distribution proposal for 2024 as Cash dividend/10 shares : CNY 1.10000000.... April 13, 2024 ... Financials . Sales 2024: 2 836 M 412 M 412 M: Net income 2024: 104 M 15,1 M 15,1 M: Net Debt 2024: 136 M 19,7 M 19,7 M: P/E ratio 2024: 22,2x: Yield 2024-Capitalization: WebApr 10, 2024 · Finance. The trading price of Geron Corporation (NASDAQ:GERN) closed higher on Thursday, April 06, closing at $2.05, 2.50% higher than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $1.97 and $2.085. In examining the 52-week price action we see that the stock hit a 52 …

Geron Corporation (GERN) Stock Price & News - Google …

WebGet the latest Geron Corporation (GERN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. WebJun 22, 2024 · Geron Financial Overview. Geron's market cap is currently ―. The company's EPS TTM is $-0.366; its P/E ratio is -5.60; Geron is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $-0.10. See an overview of income statement, balance sheet, and cash flow financials. Dec 22. paliperidone oral https://twistedjfieldservice.net

Geron (GERN) Financial Statements - TipRanks

WebGeron Corporation, a biopharmaceutical company, develops biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, … WebJan 4, 2024 · The year has started well, with Geron Corporation ( NASDAQ: GERN) producing superb data, data that makes imetelstat approvable after over a decade of trial … WebApr 6, 2024 · A high-level overview of Geron Corporation (GERN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. エアコン 6時間つけっぱなし 電気代

Geron Corporation - Geron to Announce Third Quarter 2024 Financial ...

Category:Geron Corp (GERN) 10K Annual Reports & 10Q SEC Filings

Tags:Geron financials

Geron financials

Geron Williams - Financial Marketing Director - LinkedIn

WebApr 10, 2024 · Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in ... WebAug 11, 2024 · For the second quarter of 2024, the Company reported a net loss of $28.1 million, or $0.07 per share, compared to $29.6 million, or $0.09 per share, for the comparable 2024 period. Net loss for the first six months of 2024 was $58.2 million, or $0.16 per share, compared to $57.4 million, or $0.18 per share, for the comparable 2024 period.

Geron financials

Did you know?

WebGeron Corporation Common Stock (GERN) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. WebMar 27, 2024 · Detailed financial statements for Geron (GERN), including the income statement, balance sheet, and cash flow statement. ... Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual and quarterly reports submitted to the Securities and Exchange Commission (SEC). Sections ...

Web1 day ago · Thursday, April 20 at 10:15 a.m. ET. Stifel 2024 Virtual Targeted Oncology Days. Tuesday, April 25 at 2:00 p.m. ET. A webcast of each fireside chat and corporate presentation will be available through the Investor Relations section of Geron’s website under Events. Following each scheduled conference event, the related webcast will be … WebJun 22, 2024 · Geron's market cap is currently ―. The company's EPS TTM is $-0.366; its P/E ratio is -5.60; Geron is scheduled to report earnings on May 8, 2024, and the …

WebJul 30, 2024 · Zacks Equity Research. Wall Street expects a year-over-year increase in earnings on higher revenues when Geron (GERN) reports results for the quarter ended June 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price … WebMar 27, 2024 · Detailed financial statements for Geron (GERN), including the income statement, balance sheet, and cash flow statement. ... Source: Financials are provided …

WebMar 3, 2015 · Organizational Resizing Also Announced Conference Call Scheduled for 4:30 p.m. EST Today, March 3 MENLO PARK, Calif., March 3, 2015 -- Geron Corporation (Nasdaq: GERN) today reported financial ...

WebMarketing Director at Pinnacle Elite. With over 5 years of financial marketing experience, I have the privilege to educated and serve my … paliperidone palmitate 1WebMar 16, 2024 · Fourth Quarter and Full Year 2024 Results. For the fourth quarter of 2024, the Company reported a net loss of $42.6 million, or $0.10 per share, compared to … paliperidone oral to invega sustennaWebDec 21, 2024 · On January 25, 2024, the Delaware Court of Chancery entered a Scheduling Order with Respect to Notice and Settlement Hearing (the "Scheduling Order"), and set a final settlement approval hearing for May 17, 2024, at 11:00 a.m. EST by telephone. A copy of the Stipulation was filed as Exhibit 99.1 to the Company's Form 8-K filed on December … paliperidone offersWebMay 10, 2024 · FOSTER CITY, Calif.--(BUSINESS WIRE)-- Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, to treat hematologic myeloid malignancies, today reported financial results for the first quarter ended March 31, 2024, as well as company … エアコン 6畳 価格 工事費込みWebDec 23, 2004 · Detailed price information for Geron Corp (GERN-Q) from The Globe and Mail including charting and trades. paliperidone oral half lifeWebMar 9, 2024 · Geron will host a conference call to discuss the financial results as well as upcoming milestones at 4:30 p.m. ET the same day. FOSTER CITY, Calif., March 09, 2024--Geron Corporation (Nasdaq: GERN ... エアコン 6畳 型落ち 三菱WebGeron Corporation Reports Fourth Quarter and Full-Year 2024 Financial Results and Upcoming Milestones. Learn more. Geron Announces Positive Top-Line Results from … エアコン 6畳 以下